Saraca Laboratories Limited ...Back

Innovating, in more ways than one

Saraca Laboratories was established in 1992 with an aim to manufacture Bulk Drugs and Intermediates, and it has grown to be an innovator of sorts. Saraca started production of Ranitidine Hcl in 1998 and in a short span of time has become one of the largest manufacturers in the world. The production plant is located in an area of 30 acres and comprises of 4 production blocks with over 100 reactors. A fullfledged R&D centre and pilot plant complement the production facilities.

Saraca's core competence lies in the development of cost-effective processes for APIs & their intermediates with consistent quality. Wellexperienced, talented, knowledgeable, innovative organic chemists and chemical engineers lend their expertise to the process, ensuring the best quality at the lowest possible cost within a short span of time. A full-fledged Environmental Health & Safety team promulgates the concept of sustainable development by constantly monitoring the production to make it as eco-friendly as possible.


  • ISO 14001
  • US FDA

Product capacity (per month)
Ranitidine Hcl : 150 tons
Ranitidine Base : 120 tons
NMSM : 75 tons
Cistophur Base : 120 tons